Pathology and Genomics Core
病理学和基因组学核心
基本信息
- 批准号:9404836
- 负责人:
- 金额:$ 9.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAdultAdvanced Malignant NeoplasmAfricaAmericanAreaBiologicalBiological MarkersBloodCancer DiagnosticsCervicalClinicalClinical DataCollaborationsCommunicable DiseasesCommunitiesCountryCoupledDNADNA MethylationDNA sequencingDatabasesDevelopment PlansDiagnosticEducational CurriculumEmergency SituationEpigenetic ProcessFoundationsFundingFutureGenesGenetic ResearchGenomicsGoalsHIVHealthHealthcareHepatitis BHepatitis CHistologyHuman PapillomavirusImmunohistochemistryIncomeInstitutesInstitutionInternationalInternational AIDSLaboratoriesLeadershipMalignant NeoplasmsMalignant neoplasm of cervix uteriMedicalMedical EducationMedical ResearchMethodsMethylationModernizationMolecular AnalysisNigeriaNigerianPathologyPatientsPositioning AttributePreparationPreventionPrevention ResearchPrimary carcinoma of the liver cellsProceduresRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResearch TrainingResourcesSamplingServicesSpecimenSystemTechnologyTelepathologyTimeTissuesTraining ActivityTraining ProgramsTraining SupportUnited States National Institutes of HealthUniversitiesUpdateUrineViral hepatitisVirusVirus Diseasesanticancer researchbead chipbiomedical informaticscancer carecancer geneticscareercommunity organizationsdata sharingdigitaldisorder preventionepigenomicsglobal healthimprovedinfrastructure developmentinter-institutionalinterdisciplinary approachinterestinternational centermedical schoolsoperationprogramsrepositoryresponsestatisticstoolwhole genome
项目摘要
Project Summary
We propose to establish a Consortium to study “Epigenomic Biomarkers of HIV-Associated Cancers in Nigeria.”
Our research focus and core services development plan has been prioritized by our Nigerian partners at
University of Jos (UniJos), Plateau State, Nigeria located in the center of the country and University of Lagos
(UniLag), Lagos State in the densely populated southwest. Our focus on the epigenetics of HIV-associated
hepatocellular carcinoma (HCC) and cervical cancer is justified by our extensive collaborative research history
in viral diseases including HIV, human papilloma virus, hepatitis B and C viruses. Northwestern University and
Mayo Medical School will serve as the high-income American partner institutions which is justified by the long
history of research and research training collaboration with the Nigerian institutions coupled with its expertise in
global health and ample complementary resources. The specific aims of the Pathology and Genomics Core
(PGC) are: 1. to enhance the existing laboratory systems to develop high-quality services in telepathology,
immunohistochemistry (IHC), cancer biospecimen repository, and molecular analyses at UniJos and UniLag, 2.
to develop a collaborative pathology and genomics laboratory team focused on providing core services for HIV-
associated cancer genetics research in Nigeria, and 3. to provide oversight and support for the pathology and
genomics needs of Projects 1 (HCC) and 2 (cervical) proposed under this U54. Our PGC will provide
investigators from UniJos and UniLag with high quality patient-derived biospecimens and the laboratory tools to
advance cancer research. To accomplish this, our PGC will maintain, update, and incorporate new standard
operating procedures, laboratory methods and technologies. Our PGC will be functionally divided into three
divisions/units: 1. Pathology Diagnostics: this includes all related tasks of routine histology, IHC and digital
telepathology, 2. Biospecimen Repository: this includes tissue and biospecimen procurement, detailed sample
annotation and well-controlled biospecimen banking procedures, and 3. Genomic Analysis: this includes DNA
extraction/preparation, qPCR for specific gene sequences, whole genome and epigenetic sequencing for DNA
methylation using Illumina Infinium Methylation EPIC BeadChip. The proposed PGC will utilize a strong
interdisciplinary approach involving several U54 investigators who represent a broad range of research
interests/expertise across UniJos, UniLag, Northwestern and Mayo. The overall goal of the PGC will be to
support and facilitate research proposed in Projects 1 (HCC) and 2 (cervical), provide facilities for training
activities under the Career Enhancement Core (CEC), coordination of research services with the Biomedical
Informatics and Statistics Core (BISC), build infrastructure and research management with the Administrative
Core (AC).
项目摘要
我们建议建立一个联盟,以研究“尼日利亚与HIV相关癌症的表观基因组生物标志物”。
我们的研究重点和核心服务开发计划已由我们的尼日利亚合作伙伴优先考虑
乔斯大学(UNIJOS),尼日利亚高原州,位于该国中心和拉各斯大学
(unilag),拉各斯州位于人口稠密的西南。我们关注与HIV相关的表观遗传学
我们广泛的合作研究历史证明了肝细胞癌(HCC)和宫颈癌是合理的
在病毒疾病中,包括HIV,人乳头瘤病毒,乙型肝炎和C病毒。西北大学和
梅奥医学院将担任高收入美国合作伙伴机构
研究与研究培训的历史与尼日利亚机构合作,并在其方面的专业知识
全球健康和充足的互补资源。病理和基因组核心的具体目的
(PGC)是:1。为了增强现有的实验室系统,以开发心脏病学高质量服务,
免疫组织化学(IHC),癌症生物环体存储库和Unijos and Unilag的分子分析,2。
开发一个协作病理学和基因组学实验室团队,致力于为HIV提供核心服务
尼日利亚相关的癌症遗传学研究,3。
根据U54提出的项目1(HCC)和2(宫颈)的基因组需求。我们的PGC将提供
Unijos和Unilag的调查人员具有高质量的患者衍生的生物测量和实验室工具
预先癌症研究。为此,我们的PGC将维护,更新和合并新标准
操作程序,实验室方法和技术。我们的PGC将在功能上分为三个
部门/单位:1。病理学诊断:这包括所有常规组织学,IHC和数字的所有相关任务
远程病理学,2。生物传播存储库:这包括组织和生物循环采购,详细的样品
注释和控制良好的生物测量银行程序和3。基因组分析:这包括DNA
提取/制备,特定基因序列的qPCR,整个基因组和表观遗传测序DNA
使用Illumina Infinium甲基化史诗般的Beadchip甲基化。拟议的PGC将利用强度
跨学科方法涉及几位代表广泛研究的U54调查人员
Unijos,Unilag,Northwestern和Mayo的利益/专业知识。 PGC的总体目标将是
支持和促进项目1(HCC)和2(宫颈)中提出的研究提供培训的设施
职业增强核心(CEC)下的活动,研究服务与生物医学的协调
信息学和统计核心(BISC),通过行政管理建立基础架构和研究管理
核心(AC)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jian-Jun Wei其他文献
Jian-Jun Wei的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jian-Jun Wei', 18)}}的其他基金
MiR-182 overexpression in early tumorigenesis of high grade serous carcinoma
MiR-182在高级别浆液性癌早期肿瘤发生中的过表达
- 批准号:
8606832 - 财政年份:2013
- 资助金额:
$ 9.91万 - 项目类别:
MiR-182 overexpression in early tumorigenesis of high grade serous carcinoma
MiR-182在高级别浆液性癌早期肿瘤发生中的过表达
- 批准号:
8445674 - 财政年份:2013
- 资助金额:
$ 9.91万 - 项目类别:
Racial Disparity for miRNAs in Uterine Leiomyomas
子宫肌瘤中 miRNA 的种族差异
- 批准号:
7661236 - 财政年份:2009
- 资助金额:
$ 9.91万 - 项目类别:
Racial Disparity for miRNAs in Uterine Leiomyomas
子宫肌瘤中 miRNA 的种族差异
- 批准号:
7835776 - 财政年份:2009
- 资助金额:
$ 9.91万 - 项目类别:
相似海外基金
Developing a Risk Index for Functional Decline in Middle-Aged and Older Adults with HIV
制定中老年艾滋病毒感染者功能衰退的风险指数
- 批准号:
10762280 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别:
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
- 批准号:
10762645 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别: